A daily dose of aspirin may decrease the risk for melanoma, the deadliest form of skin cancer. The new information appears in Cancer, the American Cancer Society’s medical journal.
The research team collected data on nearly 60,000 white women from 50 to 79 years old who were followed for 12 years. Participants came from the Women’s Health Initiative, a long-term national research project. The study showed that the women who took 81 milligrams of aspirin daily had a 21 percent lower risk of developing melanoma than those who did not take aspirin.
These are the most exciting results that I have seen in helping to prevent melanoma. While it is too early to recommend a daily aspirin to all women, I think the benefits outweigh the risks for patients with a family history of melanoma.